Publication | Closed Access

Limonin, a novel AMPK activator, protects against LPS-induced acute lung injury

Acute Lung InjuryInflammationPulmonary Arterial HypertensionPulmonary CirculationInflammatory Lung DiseaseLung InflammationMedicineRespiratory ToxicologyPulmonary PhysiologyPulmonary PharmacologyPulmonary MedicinePharmacologyNovel Ampk ActivatorPulmonary Vascular Disease